SCHEMBL23639738

SCHEMBL23639738

CCc1ccc(OC(=O)c2ccccc2)c(OC)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.72
MEN1 O00255 2/20 0.72
TDP1 Q9NUW8 2/20 0.72
CYP3A4 P08684 1/20 0.72
L3MBTL1 Q9Y468 1/20 0.72
SYK P43405 1/20 0.55
VCP P55072 1/20 0.55
HPGD P15428 2/20 0.54
MAPT P10636 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.51
LMNA P02545 2/20 0.51
HTT P42858 1/20 0.51
ADRB2 P07550 1/20 0.51
ADRB1 P08588 1/20 0.51
ADRB3 P13945 1/20 0.51
SLC6A3 Q01959 1/20 0.50
LDHA P00338 1/20 0.50
ALPL P05186 1/20 0.49
POLB P06746 1/20 0.49
ALPI P09923 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31321630 1.00 KMT2A (0.72) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL2510239 0.92 KMT2A (0.61) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL31321665 0.90 MAPT (0.61) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL2819604 0.90 KMT2A (0.67) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL16610045 0.89 KMT2A (0.71) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL9340141 0.88 KMT2A (0.69) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL31321621 0.86 KMT2A (0.59) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL31321661 0.86 MAPT (0.56) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL31321697 0.86 KMT2A (0.71) KMT2AMEN1TDP1CYP3A4L3MBTL1
SCHEMBL29013222 0.85 LDHA (0.54) KMT2AMEN1TDP1CYP3A4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214644-A1 PERFUME PRECURSOR TAKASAGO INTERNATIONAL CORPORATION (JP) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214644-A1 PERFUME PRECURSOR CYP2E1, ADH1A, CYP1A1 KMT2A 2414/4885MEN1 2737/4885TDP1 3060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.